| Cutaneous Melanoma Detection and Management | Lifetime | 327 | IT 27 | 97.70 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 456 | IT 30 | 95.88 |
| melanin and skin pigmentation | Lifetime | 571 | IT 30 | 94.90 |
| Melanoma and MAPK Pathways | Lifetime | 512 | IT 21 | 95.10 |
| Cutaneous lymphoproliferative disorders research | Lifetime | 654 | IT 64 | 94.53 |
| Autoimmune and Inflammatory Disorders | Lifetime | 752 | IT 69 | 90.20 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 304 | IT 39 | 85.64 |
| Dermatology and Skin Diseases | 2021-2025 | 90 | IT 12 | 98.55 |
| Cutaneous Melanoma Detection and Management | 2021-2025 | 140 | IT 17 | 95.68 |
| Asthma and respiratory diseases | 2021-2025 | 362 | IT 53 | 96.70 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 159 | IT 30 | 96.80 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 116 | IT 20 | 94.49 |
| Melanoma and MAPK Pathways | 2021-2025 | 103 | IT 10 | 94.42 |
| melanin and skin pigmentation | 2021-2025 | 146 | IT 9 | 90.47 |
| Colorectal and Anal Carcinomas | 2021-2025 | 375 | IT 30 | 91.07 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 424 | IT 48 | 93.17 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 78 | IT 13 | 91.60 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 338 | IT 50 | 89.58 |
| Nonmelanoma Skin Cancer Studies | 2021-2025 | 338 | IT 57 | 87.31 |
| Microscopic Colitis | 2021-2025 | 930 | IT 111 | 86.23 |
| Urticaria and Related Conditions | 2021-2025 | 504 | IT 41 | 83.86 |
| Skin Protection and Aging | 2021-2025 | 624 | IT 36 | 79.26 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 876 | IT 76 | 80.67 |
| Dermatologic Treatments and Research | 2021-2025 | 872 | IT 73 | 74.91 |
| Nail Diseases and Treatments | 2021-2025 | 742 | IT 52 | 73.35 |
| Hair Growth and Disorders | 2021-2025 | 497 | IT 19 | 72.75 |
| Dermatological and COVID-19 studies | 2021-2025 | 287 | IT 66 | 69.85 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 502 | IT 47 | 70.75 |
| Contact Dermatitis and Allergies | 2021-2025 | 850 | IT 59 | 70.24 |
| Chemotherapy-related skin toxicity | 2021-2025 | 258 | IT 21 | 64.15 |
| Genetic and rare skin diseases. | 2021-2025 | 448 | IT 46 | 53.80 |